Trials / Recruiting
RecruitingNCT03775837
Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults
Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults: a Randomized, Double-blinded, Placebo-controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Pusan National University Yangsan Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Panax Ginseng C.A. Mey Extract on liver function in adults for 8 weeks.
Detailed description
Previous studies have indicated that Panax Ginseng C.A. Mey Extract may have the ability to improve liver function. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the Panax Ginseng C.A. Mey Extract on liver function in adults; the safety of the compound are also evaluate. The Investigators examine AST, ALT, GGT, and other metabolic parameters at baseline, as well as after 4 and 8 weeks of intervention. Sixty adults were administered either 600 mg of Panax Ginseng C.A. Mey Extract or a placebo each day for 8 weeks;
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Panax Ginseng C.A. Mey Extract group | This group takes Panax Ginseng C.A. Mey Extract for 8 weeks |
| DIETARY_SUPPLEMENT | Placebo group | This group takes placebo for 8 weeks |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2025-12-30
- Completion
- 2025-12-31
- First posted
- 2018-12-14
- Last updated
- 2025-06-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03775837. Inclusion in this directory is not an endorsement.